ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7

Mostrar otras versiones (1)

We investigated ChAdOx1 nCoV-19 (AZD1222) vaccine efficacy against SARS-CoV-2 variants of concern (VOCs) B.1.1.7 and B.1.351 in Syrian hamsters. We previously showed protection against SARS-CoV-2 disease and pneumonia in hamsters vaccinated with a single dose of ChAdOx1 nCoV-19. Here, we observed a...

Descripción completa

Detalles Bibliográficos
Autores principales: Fischer, Robert J., van Doremalen, Neeltje, Adney, Danielle R., Yinda, Claude Kwe, Port, Julia R., Holbrook, Myndi G., Schulz, Jonathan E., Williamson, Brandi N., Thomas, Tina, Barbian, Kent, Anzick, Sarah L., Ricklefs, Stacy, Smith, Brian J., Long, Dan, Martens, Craig, Saturday, Greg, de Wit, Emmie, Gilbert, Sarah C., Lambe, Teresa, Munster, Vincent J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987006/
https://www.ncbi.nlm.nih.gov/pubmed/33758847
http://dx.doi.org/10.1101/2021.03.11.435000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987006/
https://www.ncbi.nlm.nih.gov/pubmed/33758847
http://dx.doi.org/10.1101/2021.03.11.435000

Ejemplares similares